Brief: Varex Imaging Q3 Revenue USD 203 Million Vs. IBES Estimate USD 190.3 Million

Varex Imaging

07/08/2025 21:22

Overview

Varex fiscal Q3 revenue of $203 mln beats analyst expectations, per LSEG data

GAAP net loss of $2.15 per share

Non-GAAP EPS rises to $0.18

Outlook

Company expects Q4 revenue between $210 mln and $230 mln

Varex anticipates non-GAAP EPS of $0.10-$0.30 for Q4

Company forecasts 3% sales growth for fiscal year 2025

Result Drivers

INDUSTRIAL SEGMENT - Strong performance with a 1% revenue increase year-over-year, per CEO Sunny Sanyal

CHINA MEDICAL REVENUE - Better-than-expected performance in China contributed to Medical segment revenue

CARGO INSPECTION - Continued adoption of systems in cargo inspection applications supported results, per CEO Sunny Sanyal

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q3 Revenue
Beat
$203 mln
$190.30 mln (5 Analysts)
Q3 Net Income
-$89.10 mln
Q3 Gross Margin
33.0%
Q3 Operating Income
-$80.70 mln
Q3 Pretax Profit
-$86.60 mln


Analyst Coverage

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy", 1 "hold" and no "sell" or "strong sell"

The average consensus recommendation for the advanced medical equipment & technology peer group is "buy"

Wall Street's median 12-month price target for Varex Imaging Corp is $16.00, about 56% above its August 6 closing price of $7.04

The stock recently traded at 10 times the next 12-month earnings vs. a P/E of 11 three months ago

Press Release: ID:nBw2NgrHla

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)